ATA Guidelines Tools

Anaplastic Thyroid Cancer ATA 2021

American Thyroid Association Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/1441026

Contents of this Issue

Navigation

Page 3 of 27

Key Background 4 Terms and Definitions TNM Staging ➤ All ATCs are stage 4 (AJCC 8th Edition). Stage IVA lesions (T1-T3a, N0, M0) are still localized within the thyroid gland and have not definitely spread to lymph nodes (N0) or to distant sites (M0). In Stage IVB ATC, the primary tumor has grown outside/through the thyroid capsule (T3b, T4) and/or is involving locoregional lymph nodes (≥N1), but it has not spread to distant sites (M0). In Stage IVC (Any T, Any N, M1), the tumor has spread to distant site(s). Extent of Resection ➤ R0 designates complete resection with negative microscopic margins, R1 designates complete resection of all grossly visible tumors but with involved surgical resection margins (microscopically involved resection margins), and R2 designates resection in which gross cancer was left in place (macroscopically involved resection margins). Adjuvant Therapy and Neoadjuvant Therapy ➤ Radiation, systemic therapy, or the combination given after surgery with curative intention is referred to as adjuvant therapy; and when given before surgery, neoadjuvant therapy. Table 1. Key Steps in the Management of Anaplastic Thyroid Cancer (cont'd) 7. Non-surgical management decision making Other than surgery, options may include post-operative or primary chemoradiation versus palliative radiotherapy, systemic therapy or best supportive care considered within the context of: • Patient goals of care and willingness to accept anticipated toxicities of presented options • Patient performance status and comorbidities and their impacts on feasibility of planned care • Trade-offs from one approach to care versus alternatives 8. Keep hospice/end of life care discussions in the foreground • Given the historically dire prognosis of ATC, especially if stage IVC, hospice should always be presented among care options. • Truth telling and realistic presentation of anticipated prognosis are critical in allowing sound patient decisions within their individual goals of care. • For some patients, hospice may be preferable—even from the outset—in comparison with other alternative care options.

Articles in this issue

Archives of this issue

view archives of ATA Guidelines Tools - Anaplastic Thyroid Cancer ATA 2021